Morning Market Losers

Regado Biosciences RGDO shares dipped 52.82% to $1.34 after the company reported that it had permanently terminated the Regulate-PCI clinical trial. Qihoo 360 Technology Co QIHU shares declined 7.13% to $94.50 on Q2 results. Qihoo 360 reports Q2 adjusted EPADS of $0.50 on revenue of $317.90 million. Neovasc NVCN shares fell 6.77% to $5.09. Evogene EVGN slipped 6.42% to $13.12. Evogene shares have jumped 143.83% over the past 52 weeks, while the S&P 500 index has gained 20.02% in the same period. Greif GEF shares tumbled 5.96% to $47.30 after the company cut its FY14 earnings forecast. Optibase OBAS shares declined 5.16% to $5.88. On Friday, Optibase posted Q2 net income of $159,000, up from $619,000 in the year-ago period. Leju Holdings LEJU dropped 5.06% to $17.48.